Epiheart
Epiheart
  • Home
  • Technology
  • About Us
  • Collaboration
  • Positions
  • Contact
  • More
    • Home
    • Technology
    • About Us
    • Collaboration
    • Positions
    • Contact
  • Home
  • Technology
  • About Us
  • Collaboration
  • Positions
  • Contact

Dedicated to enable surgical administration of novel cellular and gene therapies.

image220

the company

Collaboration

the company

EpiHeart is a University spin-off company leveraging over 10 years of dedicated research conducted on three continents. We are based in Helsinki, Finland, where we continue collaboration with University of Helsinki, Helsinki University Hospital "HUS" and Aalto University.



Read more
image221

Our Focus

Collaboration

the company

EpiHeart is dedicated to enable new treatments that improve long term survival and quality of life of cardiac patients. Our initial focus is in Cardiac Micrograft Therapy™. The pre-clinical and clinical results indicate positive effects on ventricular wall structure and scar size - critical factors contributing to heart failure. 


Read more
image222

Collaboration

Collaboration

Collaboration

EpiHeart is conducting clinical studies. We are open for collaboration with EU and US based cardiac surgery units and distributors. Our collaboration covers also research and commercial partnerships related to advanced cell and gene therapies that could be administered surgically. 



Read more

epiheart explained

Introductory video from the successful funding campaign. (English subtitles available)

Subscribe

Follow EpiHeart in social media


Copyright © 2021 Epiheart - All Rights Reserved.

  • Technology
  • About Us
  • Collaboration
  • Positions
  • Contact

Powered by GoDaddy Website Builder